US Patent 7750160 Isoxazolyl urea derivatives as kinase modulators
Patent 7750160 was granted and assigned to Ambit Biosciences on July, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 18 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+324 characters)
Article
Patent abstract
The invention provides methods and compositions for treating conditions mediated by various kinases wherein derivatives of urea compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+6 properties)
Infobox
Patent Inventor Names
Andiliy G. Lai0
David J. Lockhart0
Hitesh K. Patel0
Robert M. Grotzfeld0
Shamal A. Mehta0
Zdravko V. Milanov0
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07750160 Isoxazolyl urea derivatives as kinase modulators US Patent 7750160 Isoxazolyl urea derivatives as kinase modulators
Infobox
Patent Number
07750160
Patent Number
7750160
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 5 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07750160 Isoxazolyl urea derivatives as kinase modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07750160
Date of patent
July 6, 2010
Patent application number
10989824
Date Filed
November 15, 2004
Patent primary examiner
Find more entities like US Patent 7750160 Isoxazolyl urea derivatives as kinase modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
